Position in PFE
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$852,648
-$97,270 QoQ
Shares Held
35,409
+4.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,420
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITY HOLDING CO holds $54,117,792 across 11 Drug Manufacturers - General names. PFE ranks #6 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
23,405 | $28,072,660 | |
| 2 | ABBV |
AbbVie Inc.
|
43,975 | $11,065,869 | |
| 3 | JNJ |
Johnson & Johnson
|
29,051 | $7,378,082 | |
| 4 | AMGN |
Amgen Inc
|
12,282 | $4,447,557 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,085 | $1,424,422 | |
| 6 | PFE |
Pfizer Inc
This page
|
35,409 | $852,648 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
14,061 | $810,194 | |
| 8 | NVS |
Novartis AG
|
190 | $29,776 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $852,648 | 35,409 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $949,918 | 33,829 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $824,762 | 33,123 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $870,549 | 34,166 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $872,446 | 35,992 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $917,916 | 36,224 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $898,624 | 33,872 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $973,425 | 33,636 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $836,881 | 29,910 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $698,356 | 25,166 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $716,698 | 24,894 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $942,492 | 28,414 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,232,741 | 33,608 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,342,564 | 32,906 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,725,455 | 33,674 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,523,023 | 34,804 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,746,128 | 33,304 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,661,868 | 32,101 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $1,928,927 | 32,666 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $1,466,167 | 34,089 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,366,018 | 34,883 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,301,526 | 35,924 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,418,804 | 38,544 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,476,586 | 40,234 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $1,162,944 | 35,564 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $1,149,350 | 35,213 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||